NOAEL Studies
Cosmetic Ingredient
Polysorbate 65 NOAEL Studies
INCI: POLYSORBATE 65
CAS: 9005-71-4
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
CIR Safety Assessment 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| CIR Safety Assessment | DERMAL_ABSORPTION | =4.74 | % | Hairless mouse | dermal | 5% | Franz cells | {"absorption_percent":"Enhancement ratio: 4.74±0.23 compared to control (saline buffer); 1.75±0.29 compared to vehicle (ethanol)","citation":"42","concentration_tested":"5%","page":6,"pdf":"FR696.pdf","row_type":"dermal_absorption_study"} |
| CIR Safety Assessment | DERMAL_ABSORPTION | =4.74 | % | Hairless mouse | dermal | 5% | Franz cells | {"absorption_percent":"Enhancement ratio: 4.74±0.23 compared to control (saline buffer); 1.75±0.29 compared to vehicle (ethanol)","citation":"42","concentration_tested":"5%","page":6,"pdf":"FR696.pdf","row_type":"dermal_absorption_study"} |
| CIR Safety Assessment | DERMAL_ABSORPTION | =4.74 | % | Hairless mouse | dermal | 5% | Franz cells | {"absorption_percent":"Enhancement ratio: 4.74±0.23 compared to control (saline buffer); 1.75±0.29 compared to vehicle (ethanol)","citation":"42","concentration_tested":"5%","page":6,"pdf":"FR696.pdf","row_type":"dermal_absorption_study"} |
COSMOS DB 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | NOAEL | 1000 | mg/kg bw/day | rat | oral | 730 day | Chronic | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
| COSMOS DB | NOAEL | 5000 | mg/kg bw/day | rat | oral | NA | Multigeneration Reproductive | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
| COSMOS DB | NOAEL | 12500 | mg/kg bw/day | rat | oral | 728 day | Chronic | US FDA CFSAN PAFA; US FDA CFSAN PAFA Study |
EFSA 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| EFSA | ADI (group) | =25 | mg/kg bw/day | Consumers | - | - | ADI (group) | CHEMASSESS_ID 1059481; HAZARD_ID 13296 - OP_ID 2782 - EFSA ANS - 2015 - Scientific Opinion on the re-evaluation of polyoxyethylene sorbitan monolaurate (E 432), polyoxyethylene sorbitan monooleate (E 433), polyoxyethylene sorbitan monopalmitate (E 434), polyoxyethylene sorbitan monostearate (E 435) and polyoxyethylene sorbitan tristearate (E 436) as food additives - doi:10.2903/j.efsa.2015.4152 |
| EFSA | NOAEL | =2500 | mg/kg bw/day | Rat | oral: unspecified | 721 days | chronic/long term toxicity | ENDPOINTSTUDY_ID 698710; TOX_ID 9677 - OP_ID 2782 - EFSA ANS - 2015 - Scientific Opinion on the re-evaluation of polyoxyethylene sorbitan monolaurate (E 432), polyoxyethylene sorbitan monooleate (E 433), polyoxyethylene sorbitan monopalmitate (E 434), polyoxyethylene sorbitan monostearate (E 435) and polyoxyethylene sorbitan tristearate (E 436) as food additives - doi:10.2903/j.efsa.2015.4152 |
| EFSA | NOAEL | =2500 | mg/kg bw/day | Rat | oral: unspecified | 721 days | chronic/long term toxicity | ENDPOINTSTUDY_ID 698710; TOX_ID 9677 - OP_ID 2782 - EFSA ANS - 2015 - Scientific Opinion on the re-evaluation of polyoxyethylene sorbitan monolaurate (E 432), polyoxyethylene sorbitan monooleate (E 433), polyoxyethylene sorbitan monopalmitate (E 434), polyoxyethylene sorbitan monostearate (E 435) and polyoxyethylene sorbitan tristearate (E 436) as food additives - doi:10.2903/j.efsa.2015.4152 |
openFDA substances 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 14BGY2Y3MJ | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"14BGY2Y3MJ"} |
| openFDA substances | FDA UNII substance identifier | 14BGY2Y3MJ | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"14BGY2Y3MJ"} |
| openFDA substances | FDA UNII substance identifier | 14BGY2Y3MJ | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"14BGY2Y3MJ"} |
| openFDA substances | FDA UNII substance identifier | 14BGY2Y3MJ | UNII | - | - | - | polymer | {"approval_status":null,"molecular_formula":null,"source_table":"substance_identifiers_fda","substance_class":"polymer","unii_code":"14BGY2Y3MJ"} |